https://www.selleckchem.com/pr....oducts/sodium-ascorb
This subgroup analysis of the randomized, double-blind, phase 3 ADVOCATE study evaluated the efficacy and safety of avacopan compared with tapered prednisone in Japanese patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Patients with microscopic polyangiitis (MPA) or granulomatosis with polyangiitis (GPA) received either avacopan 30 mg twice daily for 52 weeks plus prednisone-matching placebo, or tapered prednisone over 20 weeks plus avacopan-matching placebo for 52 weeks. The two primary efficacy
Like
Comment
Share
